---
title: Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate
  cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter
  <em>SMILE</em> phase II trial
date: '2024-04-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38586081/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240408180554&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Daily online-adaptive MRgSBRT for localized prostate cancer
  resulted in an excellent overall toxicity profile without any major negative impact
  on quality of ...'
disable_comments: true
---
CONCLUSION: Daily online-adaptive MRgSBRT for localized prostate cancer resulted in an excellent overall toxicity profile without any major negative impact on quality of ...